EHS
EHS

Probiotics suppress nonalcoholic steatohepatitis and carcinogenesis progression in hepatocyte-specific PTEN knockout mice


  • Starley, B. Q., Calcagno, C. J. & Harrison, S. A. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology 51, 1820–1832 (2010).

    Article 

    Google Scholar
     

  • Tilg, H. & Moschen, A. R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol. 6, 772–783 (2006).

    CAS 
    Article 

    Google Scholar
     

  • Khan, A. et al. Understanding the effects of gut microbiota dysbiosis on nonalcoholic fatty liver disease and the possible probiotics role: recent updates. Int. J. Biol. Sci. 17, 818–833 (2021).

    CAS 
    Article 

    Google Scholar
     

  • Männistö, V. et al. Serum lipopolysaccharides predict advanced liver disease in the general population. JHEP Rep. 1, 345–352 (2019).

    Article 

    Google Scholar
     

  • Miura, K. et al. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1β in mice. Gastroenterology 139, 323-334.e7 (2010).

    CAS 
    Article 

    Google Scholar
     

  • Miura, K. et al. Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice. Hepatology 57, 577–589 (2013).

    CAS 
    Article 

    Google Scholar
     

  • Miura, K. et al. Toll-like receptor 4 on macrophage promotes the development of steatohepatitis-related hepatocellular carcinoma in mice. J. Biol. Chem. 291, 11504–11517 (2016).

    CAS 
    Article 

    Google Scholar
     

  • Okubo, H. et al. Lactobacillus casei strain shirota protects against nonalcoholic steatohepatitis development in a rodent model. Am. J. Physiol. Gastrointest. Liver Physiol. 305, 911–918 (2013).

    Article 

    Google Scholar
     

  • Park, E.-J. et al. Beneficial effects of lactobacillus plantarum strains on non-alcoholic fatty liver disease in high fat/high fructose diet-fed rats. Nutrients 12, 542 (2020).

    CAS 
    Article 

    Google Scholar
     

  • Febbraio, M. A. et al. Preclinical models for studying NASH-Driven HCC: how useful are they?. Cell Metab. 29, 18–26 (2019).

    CAS 
    Article 

    Google Scholar
     

  • Lange, N. F., Radu, P. & Dufour, J. F. Prevention of NAFLD-associated HCC: role of lifestyle and chemoprevention. J. Hepatol. 75, 1217–1227 (2021).

    CAS 
    Article 

    Google Scholar
     

  • Horie, Y. et al. Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. J. Clin. Invest. 113, 1774–1783 (2004).

    CAS 
    Article 

    Google Scholar
     

  • Stiles, B. et al. Live-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity. Proc. Natl. Acad. Sci. U. S. A. 101, 2082–2087 (2004).

    ADS 
    CAS 
    Article 

    Google Scholar
     

  • Galicia, V. A. et al. Expansion of hepatic tumor progenitor cells in pten-null mice requires liver injury and is reversed by loss of AKT2. Gastroenterology 139, 2170–2182 (2010).

    CAS 
    Article 

    Google Scholar
     

  • Hu, T. H. et al. Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma. Cancer 97, 1929–1940 (2003).

    CAS 
    Article 

    Google Scholar
     

  • Nomoto, K., Tsuneyama, K., Takahashi, H., Murai, Y. & Takano, Y. Cytoplasmic fine granular expression of 8-hydroxydeoxyguanosine reflects early mitochondrial oxidative DNA damage in nonalcoholic fatty liver disease. Appl. Immunohistochem. Mol. Morphol. AIMM 16, 71–75 (2008).

    CAS 
    Article 

    Google Scholar
     

  • Miura, K. et al. Ezetimibe suppresses development of liver tumors by inhibiting angiogenesis in mice fed a high-fat diet. Cancer Sci. 110, 771–783 (2019).

    CAS 
    Article 

    Google Scholar
     

  • Kim, B. et al. Protective effects of Lactobacillus rhamnosus GG against dyslipidemia in high-fat diet-induced obese mice. Biochem. Biophys. Res. Commun. 473, 530–536 (2016).

    CAS 
    Article 

    Google Scholar
     

  • Zhao, Z. et al. Lactobacillus plantarum NA136 ameliorates nonalcoholic fatty liver disease by modulating gut microbiota, improving intestinal barrier integrity, and attenuating inflammation. Appl. Microbiol. Biotechnol. 104, 5273–5282 (2020).

    CAS 
    Article 

    Google Scholar
     

  • Bubnov, R. V. et al. Comparative study of probiotic effects of Lactobacillus and Bifidobacteria strains on cholesterol levels, liver morphology and the gut microbiota in obese mice. EPMA J. 8, 357–376 (2017).

    Article 

    Google Scholar
     

  • Dang, X., Xu, M., Liu, D., Zhou, D. & Yang, W. Assessing the efficacy and safety of fecal microbiota transplantation and probiotic VSL#3 for active ulcerative colitis: a systematic review and meta-analysis. PLoS ONE 15, 1–16 (2020).

    Article 

    Google Scholar
     

  • Velayudham, A. et al. VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice. Hepatology 49, 989–997 (2009).

    CAS 
    Article 

    Google Scholar
     

  • Esposito, E. et al. Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats. J. Nutr. 139, 905–911 (2009).

    CAS 
    Article 

    Google Scholar
     

  • Ishioka, M., Miura, K., Minami, S., Shimura, Y. & Ohnishi, H. Altered gut microbiota composition and immune response in experimental steatohepatitis mouse models. Dig. Dis. Sci. 62, 396–406 (2017).

    CAS 
    Article 

    Google Scholar
     

  • Day, C. P. & James, O. F. Steatohepatitis: a tale of two ‘hits’?. Gastroenterology 114, 842–845 (1998).

    CAS 
    Article 

    Google Scholar
     

  • Yamaguchi, K. et al. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology 45, 1366–1374 (2007).

    CAS 
    Article 

    Google Scholar
     

  • Gluchowski, N. L. et al. Hepatocyte deletion of triglyceride-synthesis enzyme acyl CoA: diacylglycerol acyltransferase 2 reduces steatosis without increasing inflammation or fibrosis in mice. Hepatology 70, 1972–1985 (2019).

    CAS 
    Article 

    Google Scholar
     

  • Puri, P. et al. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology 46, 1081–1090 (2007).

    CAS 
    Article 

    Google Scholar
     

  • Caballero, F. et al. Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH. J. Hepatol. 50, 789–796 (2009).

    CAS 
    Article 

    Google Scholar
     

  • Kumar, M. et al. Effect of probiotic fermented milk and chlorophyllin on gene expressions and genotoxicity during AFB 1-induced hepatocellular carcinoma. Gene 490, 54–59 (2011).

    CAS 
    Article 

    Google Scholar
     

  • Zhang, H. L. et al. Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats. J. Hepatol. 57, 803–812 (2012).

    Article 

    Google Scholar
     

  • Li, J. et al. Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice. Proc. Natl. Acad. Sci. U. S. A. 113, E1306–E1315 (2016).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Shimizu, Y. et al. Oxidative stress and Liver X Receptor agonist induce hepatocellular carcinoma in Non-alcoholic steatohepatitis model. J. Gastroenterol. Hepatol. 36, 800–810 (2021).

    CAS 
    Article 

    Google Scholar
     

  • Kalhan, S. C. et al. Plasma metabolomic profile in nonalcoholic fatty liver disease. Metabolism 60, 404–413 (2011).

    CAS 
    Article 

    Google Scholar
     

  • Luz Martínez-Chantar, M. et al. Importane of a deficiency in S-adenosyl-L-methionine sysnthesis in the pathogenesis of liver injury. Am. J. Clin. Nutr. 76, 1177S-1182S (2002).

    Article 

    Google Scholar
     

  • Wong, V.W.-S., Adams, L. A., de Lédinghen, V., Wong, G.L.-H. & Sookoian, S. Noninvasive biomarkers in NAFLD and NASH – current progress and future promise. Nat. Rev. Gastroenterol. Hepatol. 15, 461–478 (2018).

    CAS 
    Article 

    Google Scholar
     

  • Ye, Q. et al. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 5, 739–752 (2020).

    Article 

    Google Scholar
     

  • Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313–1321 (2005).

    Article 

    Google Scholar
     

  • Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671–675 (2012).

    CAS 
    Article 

    Google Scholar
     

  • Kanda, Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 48, 452–458 (2013).

    CAS 
    Article 

    Google Scholar
     



  • Source link

    EHS
    Back to top button